Generation of PfCul1GFPKI and PfCul2KD_D10 parasites. by Zeba Rizvi (18071564)

WT host survival decreased with STAT6 KO-adapted <i>N</i>. <i>brasiliensis</i> infection. by Annabel A. Ferguson (17616286)

Decrease of body, thymus and adrenal weight after MD. by Nienke A. V. Derks (3207168)

Sema3a inhibits the differentiation of Raw264.7 cells to osteoclasts under 2Gy radiation by reducing inflammation by Bo Huang (30906)

Subjects:

Decreased apoptotic activity in <i>Axin2</i>^<i>-/-</i> FOb and POb and calvarial bones. by Shuli Li (24534)

PAMAM-DEN^CYS decreases <i>P</i>. <i>aeruginosa</i> infection in CF cells. by Scott Mackenzie Brockman (4433614)

“…(C) We quantified the number of fluorescent bacteria and found that PAMAM-DEN^CYS significantly decreased the <i>PaO1</i> counts at both MOI of 1 and 10 (**p<0.01), verifying the efficacy of PAMAM-DEN^CYS as an autophagy-inducing antibacterial nano-formulation. …”

Strain construction and targeted reconstitution. by Fitz Gerald S. Silao (9384713)

Stereotactic injection of AAV-miR-129-5p suppressed astrocyte activation in depressed mice. by Qiaozhen Qin (13159201)

Overview of varicella dynamic transmission model structure. by Lara J. Wolfson (7224623)

Subjects:

One- and 2-dose strategies with the weakly effective and the highly effective varicella vaccines: Predicted impact on incidence in the general population (per 100,000 person-years)... by Lara J. Wolfson (7224623)

Subjects:

Properties of common varicella vaccine parameters used in the analyses. by Lara J. Wolfson (7224623)

Subjects:

One-way sensitivity analysis: Tornado diagrams depicting parameter sensitivities in the comparison between no varicella vaccine vs. the 2-dose-short varicella vaccination strategy. by Lara J. Wolfson (7224623)

Subjects:

Results of the probabilistic sensitivity analysis. by Lara J. Wolfson (7224623)

Subjects:

Model calibration: Varicella seroprevalence fit. by Lara J. Wolfson (7224623)

Subjects:

Age distribution of varicella cases over 25 years after start of varicella vaccination (years since start of varicella vaccination shown on x-axis). by Lara J. Wolfson (7224623)

Subjects:

Cost-effectiveness frontier results at 100 years including "no vaccine" and the three vaccination strategies for each of the two vaccine types (weakly effective and highly effectiv... by Lara J. Wolfson (7224623)

Subjects:

Cost-effectiveness plane for Turkey comparing varicella vaccination strategies with and without inclusion of exogenous boosting and/or HZ (zoster) in results, considering only the... by Lara J. Wolfson (7224623)

Subjects:

Predicted HZ incidence with no varicella vaccine or applying three different vaccination strategies using the highly effective varicella vaccine. by Lara J. Wolfson (7224623)

Subjects:

Varicella incidence in Turkey by varicella vaccination strategy. by Lara J. Wolfson (7224623)

Subjects:

<i>In situ</i> image analysis shows decreased protein expression of desmoglein-1 and claudin-1 in the DMPA group. by Frideborg Bradley (507945)